A recent study links chemical hair relaxers to hormone-sensitive cancers
The National Institutes of Health (NIH) completed a major clinical study that found evidence that chemical hair relaxer products contain endocrine-disrupting and carcinogenic chemicals that could cause uterine cancer. The toxic hair relaxer lawsuits against SoftSheen-Carson started right after the study was published in the Journal of the National Cancer Institute on October 17, 2022. The decade-long research conducted by the National Institutes of Health reviewed data on over 33,000 women.
The study found a higher risk of uterine cancer among women who were using chemical hair relaxers compared to women who used no chemical hair relaxer products. The Chicago-based SoftSheen-Carson L'Oreal makes and sells hair relaxers that contain EDCs:
SoftSheen-Carson named as a defendant in toxic hair relaxer lawsuits
The National Institutes of Health's study led to product liability lawsuits against SoftSheen-Carson and other chemical hair relaxer manufacturers. The company faces a proposed class action over its alleged failure to disclose that some of its chemical hair straightening products contain endocrine-disrupting chemicals known to be harmful to health. Plaintiffs in these lawsuits claim that these toxic chemicals led to the development of hormone-sensitive diseases such as:
To file a toxic hair relaxer claim against SoftSheen-Carson, you should meet the following eligibility requirements:
- you must have used SoftSheen-Carson chemical hair relaxer products for at least 2 - 5 years
- you must have used SoftSheen-Carson chemical hair relaxer products at least four times a year
- you must have been diagnosed with uterine or ovarian cancer.
